检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈寅[1] 王菁[1] 冒韵东(审校)[1] CHEN Yin;WANG Jing;MAO Yun-dong(Clinical Center of Reproductive Medicine,First Affiliated Hospital of Nanjing Medical University,Nangjing 210029,China)
机构地区:[1]南京医科大学第一附属医院临床生殖医学中心,210029
出 处:《国际生殖健康/计划生育杂志》2023年第5期398-402,共5页Journal of International Reproductive Health/Family Planning
基 金:国家自然科学基金(81671438,81401267)。
摘 要:体外受精-胚胎移植(in vitro fertilization-embryo transfer,IVF-ET)是子宫内膜异位症(endometriosis,EMs)合并不孕的有效助孕方法,促性腺激素释放激素激动剂(gonadotropin-releasing hormone agonist,GnRHa)超长方案进行长期降调节有助于改善EMs合并不孕患者的妊娠结局。近年来,越来越多的促排卵方案被应用于EMs合并不孕患者,如拮抗剂方案和高孕激素状态下促排卵方案等。这些方案展现了改善EMs合并不孕患者妊娠结局的潜力,但因EMs病因不明、分期复杂和临床的异质性,EMs合并不孕患者促排卵方案的选择尚存在争议,需要更多高质量的临床研究来验证不同个体的促排卵方案的有效性。In vitro fertilization-embryo transfer(IVF-ET)is an effective method for the treatment of infertility combined with endometriosis(EMs).The ultra-long protocol of gonadotropin-releasing hormone agonist(GnRHa)for the long-term down-regulation of pituitary can help to improve pregnancy outcomes in infertile patients with EMs.In recent years,more and more ovulation induction protocols have been applied in patients with EMs-related infertility,such as gonadotropin-releasing hormone antagonist(GnRHA)protocol and progestin-primed ovarian stimulation(PPOS)protocol.These protocols have showed their potential in improving the pregnancy outcomes in patients with EMs-related infertility.However,the choice of ovulation induction protocols in patients with EMsrelated infertility is controversial due to unknown etiology,complex staging and clinical heterogeneity.It is necessary to conduct more high-quality clinical studies to validate the efficiency of these protocols in the different individuals.
关 键 词:子宫内膜异位症 控制性促排卵 排卵诱导 体外受精 胚胎移植 促性腺素释放激素 GnRH激动剂长方案 GnRH拮抗剂方案 高孕激素状态下促排卵方案 妊娠结局
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49